
Zynerba Pharmaceuticals Presents Long-Term Safety and Efficacy Data of Zygel in Children and Adolescents
DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) this week presented an oral podium presentation at the International Society for Autism Research Annual Meeting (INSAR 2022). A copy of the …
Zynerba Pharmaceuticals Presents Long-Term Safety and Efficacy Data of Zygel in Children and Adolescents Read More